Janssen Biotech, Inc.

Ethicon, Gmbh

Daphne Ann Salick Ryan

Chunlin Yang

John Wheeler

John Kehoe

Ilya S Koyfman

Qiang Zhang

Robert Vetrecin

Abla A Creasey

Philip M Steele

Ziwei Wang

Abla Creasy

We have disclosed affinity peptides toward infliximab. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for infliximab.

Affinity peptides toward infliximab

Methods for defatting omentum and processes for preparing an acellular omentum, i.e., devitalized or decellularized omentum, comprising extracellular matrix for implantation into a mammalian system. Constructs for medical applications comprising decellularized omentum are also described. More specifically, mesh reinforced omentum biomatrix for soft tissue repair is described.

Decellularized omentum matrix and uses thereof

Growing community of inventors

Manalapan, NJ, United States of America

Daphne Ann Salick Ryan